Holen Sie sich die Stockscreener-App
9.28
6.30%
0.55
Schlusskurs vom Vortag:
$8.73
Offen:
$8.85
24-Stunden-Volumen:
1.35M
Relative Volume:
1.08
Marktkapitalisierung:
$379.70M
Einnahmen:
$128.29M
Nettoeinkommen (Verlust:
$-30.69M
KGV:
-11.32
EPS:
-0.82
Netto-Cashflow:
$-27.17M
1W Leistung:
+10.08%
1M Leistung:
+27.82%
6M Leistung:
-68.65%
1J Leistung:
-82.92%
1-Tages-Spanne:
$8.76
$9.37
1-Wochen-Bereich:
$8.20
$9.37
52-Wochen-Spanne:
$6.32
$58.23
Rxsight Inc Stock (RXST) Company Profile
Firmenname
Rxsight Inc
Sektor
Branche
Telefon
949-521-7822
Adresse
100 COLUMBIA STREET, ALISO VIEJO
Vergleichen Sie RXST mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RXST
Rxsight Inc
|
9.28 | 347.38M | 128.29M | -30.69M | -27.17M | -0.82 |
|
ABT
Abbott Laboratories
|
132.59 | 226.73B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.17 | 152.69B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
394.22 | 145.89B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.71 | 118.91B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
81.83 | 45.97B | 5.69B | 1.41B | 577.90M | 6.95 |
Rxsight Inc Stock (RXST) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-15 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-07-10 | Herabstufung | Jefferies | Buy → Hold |
| 2025-07-09 | Herabstufung | BTIG Research | Buy → Neutral |
| 2025-07-09 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2025-07-09 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-05-19 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-04-15 | Eingeleitet | Piper Sandler | Neutral |
| 2025-04-09 | Herabstufung | UBS | Buy → Neutral |
| 2025-04-04 | Herabstufung | JP Morgan | Overweight → Underweight |
| 2025-04-03 | Herabstufung | BofA Securities | Buy → Underperform |
| 2024-12-20 | Herabstufung | Stifel | Buy → Hold |
| 2024-12-11 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-12-06 | Eingeleitet | UBS | Buy |
| 2024-10-29 | Eingeleitet | Jefferies | Buy |
| 2024-08-20 | Bestätigt | Needham | Buy |
| 2024-08-06 | Bestätigt | Needham | Buy |
| 2024-05-07 | Bestätigt | BTIG Research | Buy |
| 2023-12-13 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-12-12 | Eingeleitet | Stifel | Buy |
| 2023-12-04 | Eingeleitet | Morgan Stanley | Overweight |
| 2023-04-13 | Eingeleitet | Oppenheimer | Outperform |
| 2022-12-12 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-04-08 | Eingeleitet | Needham | Buy |
Alle ansehen
Rxsight Inc Aktie (RXST) Neueste Nachrichten
RXST Stockholders with Large Losses Should Contact Robbins LLP for Information About the RxSight, Inc. Class Action - PR Newswire
RXST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
RXST INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that RxSight, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewswire Inc.
Levi & Korsinsky Urges RxSight, Inc. (RXST) Shareholders to Act Before Lead Plaintiff Deadline September 22, 2025 - ACCESS Newswire
Analyzing the Impact of Earnings Reports on RxSight Inc Inc. (RXST) Price Performance - investchronicle.com
Can RxSight Inc. rally from current levelsBuy Signal & Accurate Entry/Exit Alerts - Newser
What moving averages say about RxSight Inc.Earnings Risk Report & Consistent Return Strategy Ideas - Newser
What high frequency data says about RxSight Inc.Swing Trade & Accurate Intraday Trading Signals - Newser
What to do if you’re stuck in RxSight Inc.Weekly Volume Report & AI Forecast for Swing Trade Picks - Newser
RxSight, Inc. Sued for Securities Law Violations – - GlobeNewswire
Understanding RxSight Inc.’s price movementQuarterly Portfolio Review & Expert Curated Trade Setup Alerts - Newser
DEADLINE ALERT for RXST, RMHIX, FI, and FLYW: The Law - GlobeNewswire
RXST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that RxSight, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 22, 2025 in RxSight, Inc. LawsuitRXST - Morningstar
Bleichmar Fonti & Auld Files Lawsuit Against RxSight for Securities Fraud. - AInvest
RXST SECURITIES: RxSight, Inc. Shareholders that Lost Money - GlobeNewswire
Using portfolio simulators with RxSight Inc. includedWeekly Profit Recap & Precise Swing Trade Entry Alerts - Newser
RXST LAWSUIT ALERT: Levi & Korsinsky Notifies RxSight, Inc. InvestorsLead Plaintiff Deadline September 22, 2025 - ACCESS Newswire
Class Action Lawsuit Alert: Levi & Korsinsky Reminds RxSight, Inc. (RXST) Investors of September 22, 2025 Deadline - ACCESS Newswire
RxSight Execs Face Investor’s Suit Alleging Disclosure Failures - Bloomberg Law News
Class Action Filed Against RxSight, Inc. (RXST) Seeking Recovery for Investors – Contact The Gross Law Firm - GlobeNewswire
Burned by RxSight, Inc.? Contact Levi & Korsinsky to SueWallSt And Fight Back - Stockhouse
RxSight, Inc. (RXST): A Case Study in Securities Fraud, Governance Failures, and Shareholder Risk - AInvest
Shareholders who lost money on their RxSight, Inc. (NASDAQ: - GlobeNewswire
RxSight, Inc. (RXST) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
Lost Money on RxSight, Inc. (RXST)? Join Class Action Before September 22, 2025Contact Levi & Korsinsky - ACCESS Newswire
Investors in RxSight, Inc. Should Contact The Gross Law Firm Before September 22, 2025 to Discuss Your RightsRXST - WV News
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
RxSight, Inc. Investigated for Securities Fraud ViolationsContact the DJS Law Group to Discuss Your RightsRXST - MarketScreener
RXST Investors Have Opportunity to Lead RxSight, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
Artisan Partners Ups Stake in RxSight Inc. with Strategic Acquisition - AInvest
RXST LOSS ALERT: RxSight, Inc. Investors with Losses are - GlobeNewswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages RxSight, Inc. - GlobeNewswire
RXST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that RxSight, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in RxSight, Inc. of Class Action Lawsuit and Upcoming Deadlines – RXST - FinancialContent
Class Action Filed Against RxSight, Inc. (RXST) Over Securities ViolationsContact Levi & Korsinsky Today - ACCESS Newswire
Predicting RxSight Inc. trend using moving averagesTrade Ideas & Daily Price Action Insights - Newser
Bragar Eagel & Squire, P.C. Reminds Investors of Class - GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in RxSight, Inc. of Class Action Lawsuit and Upcoming DeadlinesRXST - cnhinews.com
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of RxSight - GlobeNewswire
Deadline Alert: RxSight, Inc. (RXST) Investors Who Lost - GlobeNewswire
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of RxSight, Inc. (RXST) Shareholders - PR Newswire
Faruqi & Faruqi Reminds RxSight Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 22, 2025RXST - MarketScreener
RXST FRAUD REMINDER: RxSight, Inc. Stock Drop Triggers - GlobeNewswire
Is RxSight Inc. a strong growth stockQuarterly Risk Review & High Return Trade Guides - mustnews.co.kr
RxSight to Present at Wells Fargo Healthcare Conference, Highlighting Vision Customization Tech - AInvest
Live market analysis of RxSight Inc.Market Volume Summary & Real-Time Price Movement Reports - Newser
Can RxSight Inc. sustain earnings growthWeekly Gains Summary & High Accuracy Swing Entry Alerts - thegnnews.com
RxSight, Inc. to Present at the Wells Fargo Healthcare Conference - 富途牛牛
RXST Investors Have Opportunity to Lead RxSight, Inc. Securities Fraud Lawsuit - PR Newswire
Class Action Filed Against RxSight, Inc. (RXST)September 22, 2025 Deadline to JoinContact The Gross Law Firm - Barchart.com
Finanzdaten der Rxsight Inc-Aktie (RXST)
Umsatz
Nettogewinn
Free Cashflow
ENV
Rxsight Inc-Aktie (RXST) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Thunen Shelley B | See remarks |
Apr 14 '25 |
Option Exercise |
4.34 |
7,792 |
33,806 |
38,354 |
| Fountain Tamara | Director |
Mar 12 '25 |
Sale |
25.71 |
7,000 |
180,002 |
24,793 |
0.89%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):